Compared to TRAIL with a short serum half-life, the long-acting IgBD-TRAIL combined with Ze-IR700-mediated PDT induced greater (72.6±12.8% vs 28.3±8.7%) apoptosis in HT29 tumor grafts (Figure 7B). The gene discussed is TNFSF10; the disease is neoplasm.